Ceapro Inc. (CVE:CZO – Get Free Report)’s stock price was down 11.8% during trading on Thursday . The company traded as low as C$0.23 and last traded at C$0.23. Approximately 5,850 shares were traded during trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Price Performance
The company has a quick ratio of 18.88, a current ratio of 8.54 and a debt-to-equity ratio of 8.07. The stock has a market cap of C$17.62 million, a PE ratio of -3.75 and a beta of 1.38. The firm’s fifty day moving average price is C$0.22 and its 200 day moving average price is C$0.23.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Featured Stories
- Five stocks we like better than Ceapro
- Manufacturing Stocks Investing
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Stock Sentiment Analysis: How it Works
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- How to Profit From Growth Investing
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
